We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

May 10, 2019

Lifting the lid on 2019 Digital Health Investments so far

Commentary
Sophie Madden
&


At the beginning of 2019, we released our 2019 predictions blog based on everything we had read and heard from our members, advisors, friends at start-ups, and investors, coupled with data from the HealthXL platform.

In this weeks blog, we are going to do a roundup of some notable investments that have occurred so far in 2019, assessing the types of companies that are catching the interest of investors, and explore if these correlate to our previous predictions, if there are any new trends to add to your radar, and if trends are deceptive in what they convey about importance.


2019 Predictions

Here's a quick overview of our predictions for 2019:


2019 Investments - Where is the money going?

Looking first to our prediction around the application of artificial intelligence (AI) in healthcare, so far in 2019 we have seen a particular interest from investors in companies that leverage AI and machine learning to improve clinical performance.







On the back of the digital therapeutics rise to fame in 2018, it is no surprise to see that investors are still interested in this space.




As we predicted, interest in digital therapeutics is now turning to the question of how to get the technology into the hands of patients and physicians. Ultimately, where the prescription environment will go is towards more standardised recommendations through prescription platforms and evolving reimbursement codes.



  


Health insurance is joining the modern healthcare movement, with incumbents and newcomers leveraging technology to augment their offerings. As we predicted, health insurance is getting more digital, and investors are noticing the opportunity these solutions present to help personalise health plans, allow smart triage of queries, augment consumer engagement and retention, and improve consistency of claims and transparency.




As predicted, the competition for primary care is continuing to grow, and there is a big push towards making care more affordable and accessible. There have been some big investments in this space in 2019, and we suspect the trend will continue.





While telemedicine is one of the biggest opportunities for improving access to primary care, we are also seeing new models of care becoming popular and raising capital, with a number of primary care disruptors emerging who engage with employers, insurers, and health systems to provide their own practices enabled by a suite of technology solutions.





Clinical trial optimisation is a key priority for pharmaceutical companies. Investors have taken note and funded a wide range of solutions in recent years, from technology to enhance recruitment and retention for clinical trials, to AI and big data to find diverse sets of patients most suited for clinical trials, and remote patient monitoring and medication adherence tools to drive retention.




Other notable activity occurring so far this year include a number of investments in the direct to consumer space, with investors taking note of the continued success of companies like 23andMe, who are benefiting from the growing interest and engagement from consumers around their own health.




What next?

Where capital is being deployed is generally a good indicator of a promising area within the market, however we also need to look at other factors like partnerships, commercial traction, and whether or not these investments are being matched by sufficient evidence of the solutions ability to deliver improved healthcare outcomes, to truly understand what areas of digital health will have the biggest impact. Companies that wisely use their investment to build a solid evidence base to support their claims, and not just on growth and marketing of promises, will emerge as winners in gaining traction, and getting into tangible partnerships with incumbents, among other things.

In our Q2 Report, Digital Health Evidence Review 2019, we are aiming to identify, categorize, and summarise all existing, relevant studies in digital health. Through this report, we want to establish a clear understanding of the existing body of clinical evidence for digital health, its maturity, current gaps and needs.

Do you have specific questions on clinical validation for DH? Reach out to us - we'd love to get your ideas and answer your pain points.




We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

DTx last mile delivery - HCPs and patients adoption

2nd November @ 11:45AM EDT

Join us in this informal conversation where we will discuss the main challenges around HCP and Patient adoption of DTx. Apply now to connect with peers and learn from fellow thought leaders in this space.

Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Tech Giants, Start-ups or Incumbents, who will disrupt healthcare?

4th November @ 11:30AM EDT

Join our Digital Health Meeting as discuss How do we define disruption in the healthcare industry? What is the ‘extinction event’ healthcare needs and why has it not happened yet? And what are the learnings from Tech Giants’ moves in healthcareApply now to join the conversation and share your thoughts on the topic.

Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Anish Shindore
Anish Shindore
Head of NeuroTech & Open Innovation, Biogen
Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Anish Shindore
Anish Shindore
Head of NeuroTech & Open Innovation, Biogen
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: How to get your DTx product reimbursed in the US?

4th November @ 11:45AM EDT

Are you a DTx company seeking reimbursement in the US? Then this masterclass is for you. Join us in this US-focused interactive masterclass led by Mike Pace, who will walk us through how to get your DTx product reimbursed in the US.

Featuring
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Featuring
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: DiGa - Entering the digital health space in Germany

10th November @ 10:45AM EDT

Join us in this interactive masterclass led by Flying Health, as they discuss what you need to know to navigate the DiGa framework. Apply now to learn valuable insights from thought leaders in this space.

Featuring
Laura Nelde
Laura Nelde
Startup Relationship Manager at Flying Health
Len-Philipp Ortlepp
Len-Philipp Ortlepp
Junior Startup Relationship Manager, Flying Health
Featuring
Laura Nelde
Laura Nelde
Startup Relationship Manager at Flying Health
Len-Philipp Ortlepp
Len-Philipp Ortlepp
Junior Startup Relationship Manager, Flying Health

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

DTx last mile delivery - HCPs and patients adoption

2nd November @ 11:45AM EDT

Join us in this informal conversation where we will discuss the main challenges around HCP and Patient adoption of DTx. Apply now to connect with peers and learn from fellow thought leaders in this space.

Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Commercialisation models for Virtual Care in Respiratory Diseases

3rd November @ 11:45AM EDT

Join our Digital Health Meeting as we discuss commercialisation models for Virtual Care in Respiratory Diseases. Apply now to hear from fellow peers in this space and share your own thoughts and experiences on this topic.

Featuring
Peter Small
Peter Small
Chief Medical Officer, Hyfe
Caleb Bank
Caleb Bank
Product Marketing at NuvoAir
Featuring
Peter Small
Peter Small
Chief Medical Officer, Hyfe
Caleb Bank
Caleb Bank
Product Marketing at NuvoAir
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Tech Giants, Start-ups or Incumbents, who will disrupt healthcare?

4th November @ 11:30AM EDT

Join our Digital Health Meeting as discuss How do we define disruption in the healthcare industry? What is the ‘extinction event’ healthcare needs and why has it not happened yet? And what are the learnings from Tech Giants’ moves in healthcareApply now to join the conversation and share your thoughts on the topic.

Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Anish Shindore
Anish Shindore
Head of NeuroTech & Open Innovation, Biogen
Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Anish Shindore
Anish Shindore
Head of NeuroTech & Open Innovation, Biogen
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: How to get your DTx product reimbursed in the US?

4th November @ 11:45AM EDT

Are you a DTx company seeking reimbursement in the US? Then this masterclass is for you. Join us in this US-focused interactive masterclass led by Mike Pace, who will walk us through how to get your DTx product reimbursed in the US.

Featuring
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Featuring
Michael Pace
Michael Pace
Founder and President at PalmHealth.co

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.